China Grand Pharmaceutical and Healthcare Holdings Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations, pharmaceutical intermediates, specialized pharmaceutical raw materials, and healthcare products. The company offers pharmaceutical preparations, such as cerebro-cardiovascular, ophthalmic gel and eye drops, antibacterial, antibiotics, and antipyretics and analgesic; and active pharmaceutical ingredients (APIs), which include amino acids, analgin, and metronidazole. It also provides steroid hormones APIs and its intermediates, including glucocorticoid and sex hormones. In addition, the company offers Taurine, an organic amino acid that is used to enhance immunity system, increase level of cell differentiation, growth, and supplement in infant milk powder, as well as used in energy drinks and in treatment of certain heart diseases. Further, it manufactures ophthalmic medical devices and surgical supplies; and provides agricultural chemicals comprising bio-pesticides, biocides, and bio-feed additives; and fine chemicals, such as calcium superphosphate and dimethyl sulfate. China Grand Pharmaceutical and Healthcare Holdings Limited operates primarily in the People’s Republic of China, as well as in the United States, Europe, Asia, and internationally. The company was incorporated in 1995 and is based in Central, Hong Kong. China Grand Pharmaceutical and Healthcare Holdings Limited is a subsidiary of Outwit Investments Limited.
china grand pharmaceutical a
99 Queen’s Road
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for 512.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact CHINA GRAND PHARMACEUTICAL A, please visit www.chinagrandpharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.